JKJieun Kwon

Jieun Kwon

*This is an algorithmically generated author record based on publicly available information.

Jieun Kwon has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea

    by Soon Sun Kim, Hyun Yang, Jieun Kwon, Eunju Kim, Jeong Il Yu, Janghan Jung, Woosun Choi, Ji Eun Han, Moon Haeng Hur, Bo Hyun Kim, et al.

    In 2024, a nationwide conflict between the South Korean government and the medical community, the medical-policy conflict, profoundly impacted healthcare delivery. This study aimed to evaluate the changes in the management of hepatocellular carcinoma (HCC) following this crisis. We analyzed retrospective real-world data from university hospitals in the Seoul Metropolitan Area, supplemented with national healthcare data from the Health Insurance Review and Assessment Service. The analytical variables included changes in workforce composition, initial treatment modalities, HCC stage distribution, quality indicators for HCC care, regional and institutional variations in care delivery, and liver transplantation (LT) volume. A comparison between 2023 and 2024 revealed a marked decline in the number of medical trainees, a rise in the proportion of physician assistants, a 28.9% reduction in newly initiated HCC treatments, and an increased rate of stage IV diagnoses. Several quality indicators, including rates of multidisciplinary care and patient education, declined. The volume of LTs decreased by approximately 20% nationwide, with some regions ceasing LT procedures. The results suggest that serious disruptions occurred in HCC care following the conflict. The significant decrease in initial treatment and number of LT procedures, more advanced stages at diagnosis, and declining quality metrics indicate the emergence of healthcare gaps. Without the recovery of the clinical workforce and the reestablishment of a stable healthcare delivery system, the management of serious diseases such as HCC will remain structurally vulnerable. National-level efforts are urgently required to address regional disparities and restore essential medical services.


  • Open Access

    Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria

    by Hyun Yang, Soon Sun Kim, Seong Hee Kang, Jieun Kwon, Do Young Kim, Eunju Kim, Hyun Phil Shin, Jeong Il Yu, Jeong-Ju Yoo, Eileen L. Yoon, et al.

    This survey aimed to collect expert opinions from multidisciplinary specialists involved in the management of hepatocellular carcinoma (HCC) in Korea regarding real-world criteria for systemic therapy indications. In response to discrepancies between national reimbursement policies and clinical decision-making, members of the Korean Liver Cancer Association and Korean Association for the Study of the Liver participated in a web-based survey from February 4 to 14, 2025. A total of 89 respondents, primarily experienced clinicians, provided their views on major clinical scenarios including infiltrative HCC, bilobar multifocal disease, huge tumors, vascular invasion, extrahepatic metastasis, and transarterial chemoembolization (TACE) refractoriness. There was high agreement for including infiltrative HCC (69.7%), suspected portal vein invasion (70.8%), and TACE refractoriness (82.0%) as systemic therapy indications. TACE refractoriness, in particular, aligns with current guideline definitions. Additionally, over half of respondents (51.7%) supported extrahepatic metastasis under similar conditions. Notably, multidisciplinary discussion was emphasized across scenarios, but many respondents also favored allowing primary physician discretion in select cases. This report provides consolidated expert input to inform future updates to reimbursement policies and promote alignment with real-world clinical practice. These findings may help bridge the gap between national coverage criteria and clinical decision in systemic therapy for HCC.


  • Open Access

    Large Language Model–Assisted Surgical Consent Forms in Non-English Language: Content Analysis and Readability Evaluation

    by Namkee Oh, Jongman Kim, Sunghae Park, Sunghyo An, Eunjin Lee, Hayeon Do, Jiyoung Baik, Suk Min Gwon, Jinsoo Rhu, Gyu-Seong Choi, et al.

    Background: Surgical consent forms convey critical information; yet, their complex language can limit patient comprehension. Large language models (LLMs) can simplify complex information and improve readability, but evidence of the impact of LLM-generated modifications on content preservation in non-English consent forms is lacking. Objective: This study evaluates the impact of LLM-assisted editing on the readability and content quality of surgical consent forms in Korean—particularly consent documents for standardized liver resection—across multiple institutions. Methods: Standardized liver resection consent forms were collected from 7 South Korean medical institutions, and these forms were simplified using ChatGPT-4o. Thereafter, readability was assessed using KReaD and Natmal indices, while text structure was evaluated based on character count, word count, sentence count, words per sentence, and difficult word ratio. Content quality was analyzed across 4 domains—risk, benefit, alternative, and overall impression—using evaluations from 7 liver resection specialists. Statistical comparisons were conducted using paired 2-sided t tests, and a linear mixed-effects model was applied to account for institutional and evaluator variability. Results: Artificial intelligence–assisted editing significantly improved readability, reducing the KReaD score from 1777 (SD 28.47) to 1335.6 (SD 59.95) (P<.001) and the Natmal score from 1452.3 (SD 88.67) to 1245.3 (SD 96.96) (P=.007). Sentence length and difficult word ratio decreased significantly, contributing to increased accessibility (P<.05). However, content quality analysis showed a decline in the risk description scores (before: 2.29, SD 0.47 vs after: 1.92, SD 0.32; P=.06) and overall impression scores (before: 2.21, SD 0.49 vs after: 1.71, SD 0.64; P=.13). The linear mixed-effects model confirmed significant reductions in risk descriptions (β₁=−0.371; P=.01) and overall impression (β₁=−0.500; P=.03), suggesting potential omissions in critical safety information. Despite this, qualitative analysis indicated that evaluators did not find explicit omissions but perceived the text as overly simplified and less professional. Conclusions: Although LLM-assisted surgical consent forms significantly enhance readability, they may compromise certain aspects of content completeness, particularly in risk disclosure. These findings highlight the need for a balanced approach that maintains accessibility while ensuring medical and legal accuracy. Future research should include patient-centered evaluations to assess comprehension and informed decision-making as well as broader multilingual validation to determine LLM applicability across diverse health care settings.


  • Open Access

    Necessity of induction agent modification for old age kidney transplant recipients

    by Kyeong Deok Kim, Kyo Won Lee, Jae Berm Park, Woo Sung Sim, Manuel Lim, Eun Sung Jeong, Jieun Kwon, Jaehun Yang

    Background: Immunosenescence gradually deteriorates the function of the immune system, making elderly patients susceptible to infection, while reducing rejection of organ transplants. Therefore, age-adaptive immunosuppression is necessary in the elderly. We evaluated clinical outcomes such as rejection and infection rate when using basiliximab and rabbit anti-thymocyte globulin (r-ATG) as induction agents in elderly and young organ transplant recipients. Methods: We retrospectively reviewed patients who underwent kidney transplantation (KT) between June 2011 and April 2019. We enrolled 704 adult KT patients and classified the patients into groups according to patient age. We compared the outcomes of infection and biopsy-proven acute rejection (BPAR) according to the type of induction agent (basiliximab and r-ATG [4.5 mg/kg]). Results: The patient group included 520 recipients (74.6%) in the younger recipient group and 179 recipients (25.4%) in the older recipient group. When r-ATG was used as an induction agent, BPAR within 6 months occurred less (p = 0.03); however, infections within 6 months were higher in older recipients. Deaths due to infection were more common in older recipients (p = 0.003). Conclusion: It may be necessary to use less intensive induction therapy for older recipients, of which dose reduction of r-ATG is one option.


  • Open Access

    Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis

    by Jieun Kwon, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh

    Jieun Kwon, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh. Ann Liver Transplant 2023;3:104-12. https://doi.org/10.52604/alt.23.0022


  • Risk factors associated with surgical morbidities of laparoscopic living liver donors

    by Jieun Kwon, Jinsoo Rhu, Gyu-Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh

    Jieun KWON, Jinsoo RHU, Gyu-Seong CHOI*, Jong Man KIM, Choon Hyuck David KWON, Jae-Won JOH. Ann Hepatobiliary Pancreat Surg 2023;27:S183. https://doi.org/10.14701/ahbps.2023S1.LV-PP-3-4

  • Improved recurrence-free survival in patients with HCC with post-transplant plasma exchange

    by Namkee Oh, Jinsoo Rhu, Jong Man Kim, Seungwook Han, Sung Jun Jo, Sunghyo An, Sunghae Park, Sang Oh Yoon, Manuel Lim, Jaehun Yang, et al.

    Total plasma exchange (TPE) can play a role in cancer treatment by eliminating immune checkpoint inhibitors. This study investigated whether TPE improved oncological outcomes in patients with HCC who underwent ABO-incompatible living donor liver transplantation (LT). The study included 152 patients who underwent ABO-incompatible living donor LT for HCC between 2010 and 2021 at Samsung Medical Center. Overall survival was analyzed using the Kaplan-Meier curve, whereas HCC-specific recurrence-free survival (RFS) was analyzed using the cumulative incidence curve after propensity score matching. Cox regression and competing risks subdistribution hazard models were used to identify the risk factors associated with overall survival and HCC-specific RFS, respectively. The propensity score matching resulted in 54 matched pairs, grouped according to whether they underwent postoperative TPE [post-transplant TPE(+)] or not [post-transplant TPE(−)]. The 5-year HCC-specific RFS cumulative incidence was superior in the post-transplant TPE (+) group [12.5% (95% CI: 3.1%–21.9%)] compared with the post-transplant TPE(−) group [38.1% (95% CI: 24.4%–51.8%), p = 0.005]. In subgroup analysis for patients with microvascular invasion and those beyond the Milan criteria, the post-transplant TPE(+) group showed significantly superior HCC-specific survival. The multivariable analysis also showed that postoperative TPE had a protective effect on HCC-specific RFS (HR = 0.26, 95% CI: 0.10–0.64, p = 0.004) and that the more post-transplant TPE was performed, the better RFS was observed (HR = 0.71, 95% CI: 0.55–0.93, p = 0.012). Post-transplant TPE was found to improve RFS after ABO-incompatible living donor LT for HCC, particularly in advanced cases with microvascular invasion and beyond Milan criteria. These findings suggest that TPE may have a potential role in improving oncological outcomes in patients with HCC undergoing LT.


  • Open Access

    Upper thigh skeletal muscle index predicts outcomes in liver transplant recipients

    by Manuel Lim, Jong Man Kim, Jaehun Yang, Jieun Kwon, Kyeong Deok Kim, Eun Sung Jeong, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh, Suk-Koo Lee

    Lim M, et al. Ann Surg Treat Res. 2023 Oct;105(4):219-227. https://doi.org/10.4174/astr.2023.105.4.219


  • Open Access

    Hepatic venous territory mapping in living donor liver transplantation using right liver graft: an objective parameter for venous reconstruction

    by Jaehun Yang, Jinsoo Rhu, Jieun Kwon, Gyu-Seong Choi, Jong Man Kim, Woo Kyoung Jeong, Jae-Won Joh

    Yang J, et al. Ann Surg Treat Res. 2023 Jun;104(6):348-357. https://doi.org/10.4174/astr.2023.104.6.348


  • Open Access

    Outcome of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): Laparoscopic and open surgical approach

    by Ji Eun Kwon, Sunghae Park, Young Ju Oh, Sang Oh Yun, Jaehun Yang, Manuel Lim, Eun Sung Jeong, Kyeong Deok Kim, Jinsoo Rhu, Gyu-Seong Choi, et al.

    Ji Eun KWON, Sunghae PARK, Young Ju OH, Sang Oh YUN, Jaehun YANG, Manuel LIM, Eun Sung JEONG, Kyeong Deok KIM, Jinsoo RHU, Gyu-Seong CHOI, Jong Man KIM*, Jae-Won JOH. Ann Hepatobiliary Pancreat Surg 2022;26:S285. https://doi.org/10.14701/ahbps.2022S1.EP-3